跳至主要内容
临床试验/NCT06498505
NCT06498505已完成4 期

HighCycle: Effect of Acetazolamide on Pulmonary Artery Pressure in Women Compared to Men. A Randomized, Placebo-Controlled, Double-Blind Parallel Trial.

University of Zurich2 个研究点 分布在 1 个国家目标入组 303 人开始时间: 2024年7月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
303
试验地点
2
主要终点
Pulmonary artery Pressure (PAP)

研究概览

简要总结

Randomized clinical trial evaluating the effect of acetazolamide on pulmonary artery pressure in women compared to men travelling to 3600 m.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 44 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy, non-smoking men and women, age 18-44 years, without any diseases and need of regular medication (including oral contraceptives).
  • BMI >18 kg/m2 and <30 kg/m2
  • Born, raised and currently living at altitudes <1000 m
  • Written informed consent
  • Premenopausal women with an eumenorrheic cycle

排除标准

  • Other types of contraceptvies (hormonal intrauterine device, vaginal ring, subcutaneous injections or implants, among others)
  • Pregnancy or nursing
  • Anaemic (haemoglobin concentration <10g/dl)
  • Any altitude trip <4 weks before the study
  • Allergy to acetazolamide and other sulfonamides

研究组 & 干预措施

WOMEN - PLACEBO oral capsule

Placebo Comparator

Placebo (capsules identically looking as acetazolamide capsules; 1 in the morning, 1 in the evening), orally. Medication starts 24 hours before ascent to 3600 m until the morning after the second night at 3600 m.

干预措施: Placebo (Drug)

MEN - PLACEBO oral capsule

Placebo Comparator

Placebo (capsules identically looking as acetazolamide capsules; 1 in the morning, 1 in the evening), orally. Medication starts 24 hours before ascent to 3600 m until the morning after the second night at 3600 m.

干预措施: Placebo (Drug)

MEN - ACETAZOLAMIDE oral capsule

Active Comparator

Acetazolamide 250 mg/day (capsules @125 mg; 1 in the morning, 1 in the evening), orally. Medication starts 24 hours before ascent to 3600 m until the morning after the second night at 3600 m

干预措施: Acetazolamide (Drug)

WOMEN - ACETAZOLAMIDE oral capsule

Active Comparator

Acetazolamide 250 mg/day (capsules @125 mg; 1 in the morning, 1 in the evening), orally. Medication starts 24 hours before ascent to 3600 m until the morning after the second night at 3600 m

干预措施: Acetazolamide (Drug)

结局指标

主要结局

Pulmonary artery Pressure (PAP)

时间窗: Day 2 at 760 m and Day 2 at 3600 m

Sex-related difference in the altitude-induced change in RV/RA in mmHg assessed by echocardiography between acetazolamide and placebo group.

次要结局

  • Lung comets(Day 2 at 760 m and Day 2 at 3600 m)
  • Parameters of right heart function(Day 2 at 760 m and Day 2 at 3600 m)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

HighCycle: Effect of Acetazolamide on Pulmonary... | 临床试验